How to Discuss a HER2-Positive Breast Cancer Diagnosis With Patients

A multistakeholder roundtable discussion, moderated by Maria Theodoulou, MD, of New York Oncology Hematology, focused on HER2-positive breast cancer diagnosis, treatment, and management. Dr. Theodoulou was joined by Andrew D. Seidman, MD, Melissa Carver, MSN, ARNP, AOCN, and Christine McGinn, MSN, APRN, ACNP-BC.

In this segment of the roundtable series, the panelists discuss how they talk to patients about a HER2-positive breast cancer diagnosis. They also speak about how to help patients understand the meaning of this diagnosis, and how to tailor treatment to an individual’s needs, preferences, and goals.

Advertisement

Latest News

Advertisement
Advertisement
Our Contributors

Expert Interviews

Conference Highlights

Cecilia BrownConferences | March 28, 2024
I-STOP is an ongoing observational, retrospective study that includes 17 centers in Italy.
Read More
Ashley Mitchum-Chapman, BSN, RN, OCNBest Practices | March 28, 2024
Learn how a team implemented early chemotherapy education for novice nurses.
Cecilia BrownConferences | March 22, 2024
There was a significant association between the intake of certain fatty acids and overall survival outcomes.
Cecilia BrownConferences | March 22, 2024
Amivantamab plus chemotherapy “significantly prolonged time to symptomatic progression” compared with chemotherapy alone.

Network Websites